The promise of longer-lasting immunity: ‘variant-proof’ Covid vaccine begins trials

On-trial jab may offer better protection against new strains of coronavirus

A nurse with a vaccine
(Image credit: Getty Images)

Trials for a “variant-proof” booster vaccine have begun in Manchester, raising hopes that the elderly and vulnerable could achieve long-lasting immunity against Covid-19.

Bolton-based couple Andrew and Helen Clarke, aged 63 and 64 respectively, were the first trial participants to receive the mRNA vaccine, which scientists hope will do away with the need to tweak jabs regularly to combat new strains, The Telegraph reported.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Explore More